HSBC Holdings’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Sell |
7,194
-11,353
| -61% | -$503K | ﹤0.01% | 1949 |
|
|
2025
Q1 | $508K | Buy |
18,547
+1,064
| +6% | +$29.1K | ﹤0.01% | 1648 |
|
|
2024
Q4 | $702K | Buy |
17,483
+4,425
| +34% | +$178K | ﹤0.01% | 1606 |
|
|
2024
Q3 | $633K | Sell |
13,058
-5,124
| -28% | -$248K | ﹤0.01% | 1546 |
|
|
2024
Q2 | $546K | Buy |
18,182
+8,139
| +81% | +$244K | ﹤0.01% | 1597 |
|
|
2024
Q1 | $404K | Sell |
10,043
-142
| -1% | -$5.71K | ﹤0.01% | 1830 |
|
|
2023
Q4 | $260K | Sell |
10,185
-3,059
| -23% | -$78K | ﹤0.01% | 1898 |
|
|
2023
Q3 | $185K | Buy |
+13,244
| New | +$185K | ﹤0.01% | 1939 |
|
|
2022
Q4 | – | Sell |
-11,256
| Closed | -$253K | – | 2605 |
|
|
2022
Q3 | $253K | Buy |
+11,256
| New | +$253K | ﹤0.01% | 2076 |
|